TMCI:NASDAQ
Treace Medical Concepts, Inc
US$ ४.४४
arrow_upward
+०.४५%(+०.०२०) 1D
नोभेम्बर १७, १६:००:०१ GMT-५ · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for TMCI...
Open
US$ ४.४४
High
US$ ४.६३
Low
US$ ४.३७
Mkt. cap
२९.११ करोड
Avg. vol.
३.०५ लाख
Volume
२.९२ लाख
52-wk high
US$ ५.४३
52-wk low
US$ १.१७
EPS
-US$ ०.८६
Beta
१.५९
Shares outstanding
६.५६ करोड
No. of employees
४५०
Open
US$ ४.४४
High
US$ ४.६३
Low
US$ ४.३७
Mkt. cap
२९.११ करोड
Avg. vol.
३.०५ लाख
Volume
२.९२ लाख
52-wk high
US$ ५.४३
52-wk low
US$ १.१७
EPS
-US$ ०.८६
Beta
१.५९
Shares outstanding
६.५६ करोड
No. of employees
४५०
News stories
From web sources and news partners
TradingView
·
१ घण्टा पहिले
S&P 500, Dow, Nasdaq Futures Power Ahead On Nvidia Outlook Beat — NVDA, TSLA, ANT In Focus
BigGo Finance
·
३ घण्टा पहिले
Wall Street Split on 2027 S&P 500 Outlook: Wells Fargo's 8,200 vs. Morgan Stanley's 8,700
ChartMill
·
३ घण्टा पहिले
S&P 500 After-Hours Gainers for Nov. 17, 2026
www.tmgm.com
·
३ घण्टा पहिले
NSA outage sends Dow Jones Industrial Average lower before Nvidia beats
Profile
Treace Medical Concepts, Inc. is a medical device company, headquartered in Ponte Vedra Beach, Florida, specializing in the design, manufacture, and marketing of foot and ankle surgical devices and biologics. Lapiplasty, Treace’s novel primary surgical product, advanced the treatment of bunions, surgically correcting the metatarsal bone, for the first time, in all three dimensions.
In March 2021, Treace announced its intent to launch an initial public offering. Trading on the Nasdaq under the ticker symbol “TMCI”, Treace opened its IPO in April 2021. Wikipedia
About Treace Medical Concepts, Inc